DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
229. 肺胞蛋白症(自己免疫性又は先天性)
Autoimmune pulmonary alveolar proteinosis
Clinical trials
/
Disease details
臨床試験数
:
44
/
薬物数
:
22
- (
DrugBank
:
7
) /
標的遺伝子数
:
3
-
標的パスウェイ数
:
14
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT00901511
(
ClinicalTrials.gov
)
July 2009
11/5/2009
Whole Lung Lavage (WLL)/Inhaled Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (PAP)
Whole Lung Lavage (WLL)/Inhaled Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) in Autoimm ...
Whole Lung Lavage Followed by Inhaled Sargramostim in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis
Whole Lung Lavage Followed by Inhaled Sargramostim in the Treatment of Autoimmune Pulmonary Alveolar ...
Pulmonary Alveolar Proteinosis
Drug:
GM-CSF [Leukine (Sargramostim)]
;Procedure: WLL
IRCCS Policlinico S. Matteo
Agenzia Italiana del Farmaco
Enrolling by invitation
18 Years
N/A
Both
18
Phase 2/Phase 3
Italy